As per our report, the size of the Immunohistochemistry Market in the Middle East & Africa is estimated to value USD 244.18 million by 2027 from USD 171.68 million in 2022, registering a growth rate of 7.3% from 2022 to 2027.
The market is predicted to grow substantially in the mentioned forecast period as well as years to follow. Immunohistochemistry is a diagnostic procedure that involves staining a fresh or preserved cancer tissue that is already removed out in the biopsy procedure. This method of diagnosis checks if there are hormone receptors present on the surface of cancer cells. Immunohistochemistry is widely used for the diagnosis of cancers and tumor antibodies. It is an essential application in medicine as it helps the doctors study the tissue distribution of an antigen.
The market in this region is expected to show high growth due to factors like the increasing population of cancer afflicted patients, developing healthcare infrastructure, rising expenditure on health, and the emerging economy of the countries.
However, large capital requirements and huge time investment on R & D activities are the main constraints for the growth of this market.
This research report on the Middle East and Africa Immunohistochemistry Market has been segmented and sub-segmented into the following categories:
By End User:
Prominent companies operating the Middle East & Africa Immunohistochemistry Market profiled in the report are F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Abcam plc, Cell Signaling Technology, Inc., and Bio SB Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org